Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors
Ouellet, Daniele, Grossmann, Kenneth F., Limentani, Giselle, Nebot, Noelia, Lan, Kevin, Knowles, Lara, Gordon, Michael S., Sharma, Sunil, Infante, Jeffrey R., Lorusso, Patricia M., Pande, Girish, Krachey, Elizabeth C., Blackman, Samuel C., Carson, Stanley W.
Published in Journal of pharmaceutical sciences (01.09.2013)
Published in Journal of pharmaceutical sciences (01.09.2013)
Get full text
Journal Article